Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E Fox

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Annals of the New York Academy of Sciences|October 31, 1996
Retinoids synergize with IL-2 to increase interferon-gamma production by peripheral blood mononuclear cells via induction of IL-12F E Fox, M Cassin, S Gottlieb, et al.
Journal of Leukocyte Biology|February 1, 1997
Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptideH Torii, J Hosoi, S Beissert, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1995
Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patientsR J Capocasale, R J Lamb, E C Vonderheid, et al.
The Journal of Investigative Dermatology|January 1, 1997
Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects on B7, interleukin 10, and interleukin 12F E Fox, M Kubin, M Cassin, et al.
Clinical and Experimental Immunology|January 1, 1997
Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresisA H Rook, S L Gottlieb, J T Wolfe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2015
Phase I study of every 2- or 3-week dosing of ramucirumab, a human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2 in patients with advanced solid tumorsE G Chiorean, H I Hurwitz, R B Cohen, et al.
Journal of the American Academy of Dermatology|December 1, 1996
Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institutionS L Gottlieb, J T Wolfe, F E Fox, et al.
Annals of the New York Academy of Sciences|October 31, 1996
The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphomaA H Rook, M Kubin, F E Fox, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Annals of the New York Academy of Sciences|October 31, 1996
Retinoids synergize with IL-2 to increase interferon-gamma production by peripheral blood mononuclear cells via induction of IL-12F E Fox, M Cassin, S Gottlieb, et al.
Journal of Leukocyte Biology|February 1, 1997
Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptideH Torii, J Hosoi, S Beissert, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1995
Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patientsR J Capocasale, R J Lamb, E C Vonderheid, et al.
The Journal of Investigative Dermatology|January 1, 1997
Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects on B7, interleukin 10, and interleukin 12F E Fox, M Kubin, M Cassin, et al.
Clinical and Experimental Immunology|January 1, 1997
Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresisA H Rook, S L Gottlieb, J T Wolfe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2015
Phase I study of every 2- or 3-week dosing of ramucirumab, a human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2 in patients with advanced solid tumorsE G Chiorean, H I Hurwitz, R B Cohen, et al.
Journal of the American Academy of Dermatology|December 1, 1996
Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institutionS L Gottlieb, J T Wolfe, F E Fox, et al.
Annals of the New York Academy of Sciences|October 31, 1996
The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphomaA H Rook, M Kubin, F E Fox, et al.
Pageof 3